Covered recipient · General Payments record
CATHY J DOBROWSKI
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$2,456.18
- Reported across 41 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $857.48 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $232.16 | 13 |
| GENZYME CORPORATION | $133.14 | 1 |
| Phathom Pharmaceuticals, Inc. | $125.02 | 1 |
| Alexion Pharmaceuticals, Inc. | $124.99 | 1 |
| Regeneron Healthcare Solutions, Inc. | $124.99 | 1 |
| Lucid Diagnostics Inc. | $117.18 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $124.99 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1094048725 | CMS |
| GENZYME CORPORATION | $133.14 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139961429 | CMS |
| Lucid Diagnostics Inc. | $117.18 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152302931 | CMS |
| PFIZER INC. | $13.52 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131572023 | CMS |
| PFIZER INC. | $3.33 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130888671 | CMS |
| PFIZER INC. | $21.58 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131535182 | CMS |
| PFIZER INC. | $6.87 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132045820 | CMS |
| PFIZER INC. | $6.64 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132069599 | CMS |
| PFIZER INC. | $23.55 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131251711 | CMS |
| PFIZER INC. | $10.17 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132066323 | CMS |
| PFIZER INC. | $9.82 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132055898 | CMS |
| PFIZER INC. | $92.07 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130874844 | CMS |
| PFIZER INC. | $13.11 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132129076 | CMS |
| PFIZER INC. | $15.82 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131160944 | CMS |
| PFIZER INC. | $10.62 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131170757 | CMS |
| PFIZER INC. | $5.06 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131403515 | CMS |
| Phathom Pharmaceuticals, Inc. | $125.02 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151161008 | CMS |
| Regeneron Healthcare Solutions, Inc. | $124.99 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114294002 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.